Federal Register of Legislation - Australian Government

Primary content

PB 75 of 2020 Determinations/Health as made
This Determination amends the National Health (Price and Special Patient Contribution) Determination 2010 by increasing the brand premium to five brands of five pharmaceutical items in addition to adding a new brand premium to six brands of six pharmaceutical items. It also removes two brands of two pharmaceutical items that no longer have a brand premium on 1 August 2020.
Administered by: Health
Registered 31 Jul 2020

 

PB 75 of 2020

 

National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 6)

 

National Health Act 1953

___________________________________________________________________________

 

I, NIKOLAI TSYGANOV, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

 

Dated    30  July 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 


_________________________________________________________________________

1          Name of Instrument

(1)          This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 6).

(2)          This Instrument may also be cited as PB 75 of 2020.

2          Commencement

This Instrument commences on 1 August 2020.

3          Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

 


Schedule 1     Amendments

[1]   Schedule 1, omit entry for Hydromorphone

[2]   Schedule 1, entry for Levodopa with carbidopa

Omit:

Levodopa with carbidopa

Tablet 100 mg‑25 mg (as monohydrate)

Oral

Sinemet 100/25

100

19.33

23.34

Substitute:

Levodopa with carbidopa

Tablet 100 mg‑25 mg (as monohydrate)

Oral

Sinemet 100/25

100

19.33

24.67

 

Tablet 250 mg-25 mg (as monohydrate)

Oral

Sinemet

100

23.84

29.19

[3]   Schedule 1, entry for Methylphenidate

omit from the column headed “Claimed Price”:                       10.00      substitute:                12.00

[4]   Schedule 1, entry for Quetiapine

Omit:

Quetiapine

Tablet (modified release) 50 mg (as fumarate)

Oral

Seroquel XR

60

10.86

15.66

 

Tablet (modified release) 150 mg (as fumarate)

Oral

Seroquel XR

60

15.36

25.36

 

Tablet (modified release) 200 mg (as fumarate)

Oral

Seroquel XR

60

31.60

33.60

 

Tablet (modified release) 300 mg (as fumarate)

Oral

Seroquel XR

60

40.59

42.59

 

Tablet (modified release) 400 mg (as fumarate)

Oral

Seroquel XR

60

55.33

57.33

Substitute:

Quetiapine

Tablet 25 mg (as fumarate)

Oral

Seroquel

60

5.43

10.08

 

Tablet (modified release) 50 mg (as fumarate)

Oral

Seroquel XR

60

10.86

15.66

 

Tablet 100 mg (as fumarate)

Oral

Seroquel

90

15.36

20.01

 

Tablet (modified release) 150 mg (as fumarate)

Oral

Seroquel XR

60

15.36

25.36

 

Tablet (modified release) 200 mg (as fumarate)

Oral

Seroquel XR

60

31.60

33.60

 

Tablet 200 mg (as fumarate)

Oral

Seroquel

60

20.93

25.58

 

Tablet (modified release) 300 mg (as fumarate)

Oral

Seroquel XR

60

40.59

42.59

 

Tablet 300 mg (as fumarate)

Oral

Seroquel

60

30.72

35.37

 

Tablet (modified release) 400 mg (as fumarate)

Oral

Seroquel XR

60

55.33

57.33

[5]   Schedule 1, entry for Rosuvastatin in the form of Tablet 5 mg (as calcium)

omit from the column headed “Claimed Price”:                       3.85        substitute:                4.45

[6]   Schedule 1, entry for Rosuvastatin in the form of Tablet 20 mg (as calcium)

omit from the column headed “Claimed Price”:                       6.51        substitute:                7.11

[7]   Schedule 1, entry for Rosuvastatin in the form of Tablet 40 mg (as calcium)

omit from the column headed “Claimed Price”:                       9.33        substitute:                10.20

[8]   Schedule 1, entry for Salbutamol

Omit:

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

Inhalation

Ventolin Nebules

20

2..48

4.04

 

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Asmol 2.5 uni‑dose

1

3.72

3.95

 

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

Inhalation

Ventollin Nebules

1

2.61

4.16

 

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Asmol 5 uni-dose

1

3.92

4.15

 

Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

Ventolin CFC-free

1

3.90

5.60

Substitute:

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

Inhalation

Ventolin Nebules

20

2..48

4.04

 

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Asmol 2.5 uni‑dose

1

3.72

3.95

 

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

Inhalation

Ventollin Nebules

1

2.61

4.16

 

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Asmol 5 uni-dose

1

3.92

4.15

 

Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)

Inhalation by mouth

Ventolin CFC-free

1

3.90

5.60

 

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)

Inhalation by mouth

Ventolin

1

4.49

6.82